Antonio Bedalov, MD, PhD

/content/dam/www/faculty-photos/B/antonio-bedalov/antonio-bedalov.jpg
Dr. Antonio Bedalov MD, PhD
FACULTY MEMBER

Antonio Bedalov, MD, PhD

Professor, Translational Science and Therapeutics Division, Fred Hutch

Professor
Translational Science and Therapeutics Division, Fred Hutch

Professor, Human Biology Division, Fred Hutch

Professor
Human Biology Division, Fred Hutch

Fax: 206.667.6519
Mail Stop: D2-190

Dr. Antonio Bedalov studies chromatin, the material that makes up the chromosomes of humans and other eukaryotes. He is learning how chromatin modifications influence important biological events within the cell’s nucleus and, in turn, how they affect development, aging and cancer formation. He also applies this knowledge to lay the groundwork for potential new therapies to treat cancer and other diseases. He has three main research areas. First, he studies how cells regulate the transcription and replication of repetitive DNA sequences. He also studies what happens when these processes break down. Second, Dr. Bedalov is developing potential cancer drugs called sirtuin inhibitors that affect a cell process for regulating gene expression. Dr. Bedalov and collaborator Dr. Julian Simon identified the first sirtuin inhibitors, including one with potent cancer-killing abilities in lab studies. Third, Dr. Bedalov studies X-chromosome inactivation, in which the cells of females silence one of their two X chromosomes. He is interested in manipulating this process as a therapy for Rett syndrome, a genetic disorder that results from a broken gene on one X chromosome. 

Other Appointments & Affiliations

Professor, Division of Hematology and Oncology, University of Washington

Professor, Division of Hematology and Oncology
University of Washington

Adjunct Associate Professor, Biochemistry, University of Washington

Adjunct Associate Professor, Biochemistry
University of Washington

Education

1989, MD in Medicine, University of Zagreb School of Medicine, Zagreb, Croatia

1993, PhD in Medical Sciences, University of Zagreb School of Medicine, Zagreb, Croatia

Find a Clinical Trial

Dr. Bedalov in the News

500 replication origins in the yeast genome? Try 5000!

Science Spotlight - March 20, 2024

Understanding the genetics of X chromosome inactivation

Science Spotlight - October 15, 2018

Breaking the Silence

News Releases - December 17, 2001